Haemonetics Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 27, 2025	Mar '25 Mar 29, 2025	Mar '24 Mar 30, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 2, 2022	Apr '21 Apr 3, 2021
Revenue	1,318	1,361	1,309	1,169	993.2	870.46
Revenue Growth (YoY)	-4.02%	3.95%	12.01%	17.67%	14.10%	-11.94%
Cost of Revenue	535.85	611.87	617.51	553.56	487.69	472.63
Gross Profit	782.42	748.96	691.55	615.1	505.5	397.84
Selling, General & Admin	436.62	436.79	431.78	376.68	340.14	275.22
Depreciation & Amortization Expenses	44.8	48.26	32.03	32.64	47.41	32.83
Research & Development	61.23	62.72	54.44	50.13	46.8	32.86
Other Operating Expenses	-11.56	-20.63	8.42	-0.38	-9.6	-32.81
Total Operating Expenses	531.11	527.14	526.67	459.06	424.75	308.09
Operating Income	251.09	221.82	164.88	156.03	80.75	89.75
Total Non-Operating Income (Expense)	-23.93	-9.75	-13.02	-14.63	-17.12	-16.83
Pretax Income	227.17	212.07	151.87	141.4	63.63	72.91
Provision for Income Taxes	51.73	44.39	34.31	26	20.25	-6.56
Net Income	175.44	167.68	117.56	115.4	43.38	79.47
Net Income to Common	175.44	167.68	117.56	115.4	43.38	79.47
Net Income Growth	34.88%	42.63%	1.87%	166.05%	-45.42%	3.85%
Shares Outstanding (Basic)	48	50	51	51	51	51
Shares Outstanding (Diluted)	48	51	51	51	51	51
Shares Change (YoY)	-6.04%	-1.30%	-0.04%	0.13%	0.12%	-1.01%
EPS (Basic)	3.65	3.33	2.32	2.27	0.85	1.57
EPS (Diluted)	3.63	3.31	2.29	2.24	0.84	1.55
EPS Growth	42.91%	44.54%	2.23%	166.67%	-45.81%	4.73%
Shares Outstanding	46.83	48.22	50.79	50.45	51.12	50.87
Free Cash Flow	308.08	142.45	143.63	81.73	75.75	71.77
Free Cash Flow Growth	116.27%	-0.82%	75.73%	7.89%	5.56%	-34.44%
Free Cash Flow Per Share	6.40	2.81	2.79	1.59	1.48	1.40
Gross Margin	59.35%	55.04%	52.83%	52.63%	50.90%	45.70%
Operating Margin	19.05%	16.30%	12.60%	13.35%	8.13%	10.31%
Profit Margin	13.31%	12.32%	8.98%	9.87%	4.37%	9.13%
FCF Margin	23.37%	10.47%	10.97%	6.99%	7.63%	8.24%
EBITDA	363.7	337.4	262.1	249.34	178.5	174.03
EBITDA Margin	27.59%	24.79%	20.02%	21.34%	17.97%	19.99%
EBIT	251.09	221.82	164.88	156.03	80.75	89.75
EBIT Margin	19.05%	16.30%	12.60%	13.35%	8.13%	10.31%
Effective Tax Rate	22.77%	20.93%	22.59%	18.39%	31.83%	-8.99%

Updated Feb 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q